Crossroad Animal Hospital is categorized under Veterinary Services, Specialties in Melbourne, FL and active since 2004.
Crossroad Animal Hospital was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Veterinary Services, Specialties business, which does work in the BOTH market, and is classified as a Veterinary Services, Specialties, under code number 541940 by the NAICS.
If you are seeking more information, feel free to contact Kevin Oppenheimer at the company’s single location by writing to 3140 Appaloosa Boulevard, Melbourne, Florida FL 32934 or by phoning (845) 586-3695. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Crossroad Animal Hospital |
Contact Person: | Kevin Oppenheimer |
Address: | 3140 Appaloosa Boulevard, Melbourne, Florida 32934 |
Phone Number: | (845) 586-3695 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2004 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B & B2C |
Business Category: | Veterinary Services, Specialties |
SIC Code: | 0742 |
NAICS Code: | 541940 |
Share This Business: |
Crossroad Animal Hospital was started in 2004 to provide professional Veterinary Services, Specialties under the SIC code 0742 and NAICS code 541940. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Kevin Oppenheimer for inquiries that concern Crossroad Animal Hospital by calling the company number (845) 586-3695, as your correspondence is most welcome. Additionally, the physical location of the single location of Crossroad Animal Hospital can be found at the coordinates 28.159044,-80.716222 as well as the street address 3140 Appaloosa Boulevard in Melbourne, Florida 32934.
For its online presence, you may visit Crossroad Animal Hospital’s website at and engage with its social media outlets through on Twitter and on Facebook.